Zenas BioPharma, Inc.ZBIOEarnings & Financial Report
Nasdaq
ZBIO Q3 2025 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-52.6M
Net Profit
$-51.5M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-1.22
Zenas BioPharma, Inc. Q3 2025 Financial Summary
Zenas BioPharma, Inc. reported revenue of $0 for Q3 2025, with a net profit of $-51.5M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-51.5M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q3 2025 |
Income Statement
| Q3 2023 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $50.0M | $0 | $0 | $10.0M | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2023 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|
| Assets | N/A | N/A | $403.4M | $333.8M | $293.1M | $322.0M |
| Liabilities | N/A | N/A | $44.0M | $49.4M | $53.5M | $125.6M |
| Equity | $-202.2M | $-288.8M | $359.4M | $284.3M | $239.6M | $196.4M |
Cash Flow
| Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Operating CF | $-31.1M | $-37.1M | $-41.7M | $-41.1M |